158 related articles for article (PubMed ID: 21934653)
21. Contrasting roles for actin in the cellular uptake of cell penetrating peptide conjugates.
He L; Sayers EJ; Watson P; Jones AT
Sci Rep; 2018 May; 8(1):7318. PubMed ID: 29743505
[TBL] [Abstract][Full Text] [Related]
22. Isothiocyanate groups of 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) inhibit cell penetration of octa-arginine (R8)-fused peptides.
Park J; Han JH; Myung SH; Kim TH
J Pept Sci; 2020 Mar; 26(3):e3237. PubMed ID: 31852026
[TBL] [Abstract][Full Text] [Related]
23. Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides.
Shangary S; Oliver CL; Tillman TS; Cascio M; Johnson DE
Mol Cancer Ther; 2004 Nov; 3(11):1343-54. PubMed ID: 15542773
[TBL] [Abstract][Full Text] [Related]
24. Targeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells.
Li R; Boehm AL; Miranda MB; Shangary S; Grandis JR; Johnson DE
Neoplasia; 2007 Oct; 9(10):801-11. PubMed ID: 17971900
[TBL] [Abstract][Full Text] [Related]
25. Intracellular delivery of peptide cargos using polyhydroxybutyrate based biodegradable nanoparticles: Studies on antitumor efficacy of BCL-2 converting peptide, NuBCP-9.
Kapoor S; Gupta D; Kumar M; Sharma S; Gupta AK; Misro MM; Singh H
Int J Pharm; 2016 Sep; 511(2):876-89. PubMed ID: 27492021
[TBL] [Abstract][Full Text] [Related]
26. Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protection.
Hallaert DY; Spijker R; Jak M; Derks IA; Alves NL; Wensveen FM; de Boer JP; de Jong D; Green SR; van Oers MH; Eldering E
Cell Death Differ; 2007 Nov; 14(11):1958-67. PubMed ID: 17703234
[TBL] [Abstract][Full Text] [Related]
27. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD.
Watkins CL; Brennan P; Fegan C; Takayama K; Nakase I; Futaki S; Jones AT
J Control Release; 2009 Dec; 140(3):237-44. PubMed ID: 19409429
[TBL] [Abstract][Full Text] [Related]
28. Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatment.
Wu Y; Ge P; Xu W; Li M; Kang Q; Zhang X; Xie J
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110386. PubMed ID: 31923940
[TBL] [Abstract][Full Text] [Related]
29. Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18).
McCarthy BA; Boyle E; Wang XP; Guzowski D; Paul S; Catera R; Trott J; Yan XJ; Croce CM; Damle R; Yancopoulos S; Messmer BT; Lesser M; Allen SL; Rai KR; Chiorazzi N
Mol Med; 2008; 14(9-10):618-27. PubMed ID: 18633450
[TBL] [Abstract][Full Text] [Related]
30. Membrane anchoring of a curvature-inducing peptide, EpN18, promotes membrane translocation of octaarginine.
Kuroki K; Sakai T; Masuda T; Kawano K; Futaki S
Bioorg Med Chem Lett; 2021 Jul; 43():128103. PubMed ID: 33984474
[TBL] [Abstract][Full Text] [Related]
31. siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat.
Al Soraj M; He L; Peynshaert K; Cousaert J; Vercauteren D; Braeckmans K; De Smedt SC; Jones AT
J Control Release; 2012 Jul; 161(1):132-41. PubMed ID: 22465675
[TBL] [Abstract][Full Text] [Related]
32. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
Yamada Y; Hashida M; Harashima H
Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
[TBL] [Abstract][Full Text] [Related]
33. Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides.
Sayers EJ; Cleal K; Eissa NG; Watson P; Jones AT
J Control Release; 2014 Dec; 195():55-62. PubMed ID: 25108152
[TBL] [Abstract][Full Text] [Related]
34. MTD-like motif of a BH3-only protein, BNIP1, induces necrosis accompanied by an intracellular calcium spike.
Park J; Han JH; Myung SH; Seo YW; Kim TH
Biochem Biophys Res Commun; 2018 Jan; 495(2):1661-1667. PubMed ID: 29222049
[TBL] [Abstract][Full Text] [Related]
35. Cancer therapeutics based on BCL-2 functional conversion.
Pearce MC; Satterthwait AC; Zhang XK; Kolluri SK
Apoptosis; 2019 Feb; 24(1-2):1-2. PubMed ID: 30612317
[No Abstract] [Full Text] [Related]
36. Bcl-2 and apoptosis in chronic lymphocytic leukemia.
Schimmer AD; Munk-Pedersen I; Minden MD; Reed JC
Curr Treat Options Oncol; 2003 Jun; 4(3):211-8. PubMed ID: 12718798
[TBL] [Abstract][Full Text] [Related]
37. Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells.
Fretz MM; Penning NA; Al-Taei S; Futaki S; Takeuchi T; Nakase I; Storm G; Jones AT
Biochem J; 2007 Apr; 403(2):335-42. PubMed ID: 17217340
[TBL] [Abstract][Full Text] [Related]
38. Cell-penetrating peptides transport therapeutics into cells.
Ramsey JD; Flynn NH
Pharmacol Ther; 2015 Oct; 154():78-86. PubMed ID: 26210404
[TBL] [Abstract][Full Text] [Related]
39. Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia.
Jewell AP
Leuk Lymphoma; 1996 Mar; 21(1-2):43-7. PubMed ID: 8907268
[TBL] [Abstract][Full Text] [Related]
40. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.
Kibria G; Hatakeyama H; Harashima H
Int J Pharm; 2011 Jun; 412(1-2):106-14. PubMed ID: 21414394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
